Market Tracker

03/24 5:16pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

87.37
Delayed Data
As of Mar 24
 +0.53 / +0.61%
Today’s Change
73.45
Today|||52-Week Range
102.49
+5.47%
Year-to-Date

Today’s Trading

Previous close86.84
Today’s open87.52
Day’s range86.82 - 87.93
Volume1,121,370
Average volume (3 months)1,153,628
Market cap$15.1B
Dividend yield--
Data as of 4:14pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-256.07%
Earnings growth (this year)+75.01%
Earnings growth (next 5 years)+127.00%
Revenue growth (last year)+27.18%
P/E ratioNM
Price/Sales12.40
Price/Book5.45

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC-0.20-0.29%
SGENSeattle Genetics Inc+0.47+0.74%
ALKSAlkermes Plc+0.20+0.34%
TSROTESARO Inc+6.38+4.15%
Data as of 4:02pm ET, 03/24/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$1.1B
Annual profit (last year)-$630.2M
Net profit margin-56.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts